Viracta Therapeutics, Inc.
VIRX
$0.0175
-$0.0038-17.84%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.22% | -22.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.22% | -30.90% | |||
| Operating Income | -6.22% | 30.90% | |||
| Income Before Tax | -7.36% | -7.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.36% | -7.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.36% | -7.54% | |||
| EBIT | -6.22% | 30.90% | |||
| EBITDA | -6.13% | 31.04% | |||
| EPS Basic | -6.89% | -7.31% | |||
| Normalized Basic EPS | -6.93% | -7.30% | |||
| EPS Diluted | -6.89% | -7.31% | |||
| Normalized Diluted EPS | -6.93% | -7.30% | |||
| Average Basic Shares Outstanding | 0.43% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
